Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals
Mark Manak(GTx (United States)), Steven D. Douglas(Purdue University West Lafayette), Lequan T Nguyen(SeraCare Life Sciences (United States)), Dmitry Moshkoff(SeraCare Life Sciences (United States)), John Meshki(Children's Hospital of Philadelphia), Pablo Tebas(University of Pennsylvania), Florin Tuluc(Children's Hospital of Philadelphia)
Cited by 36
Related Papers
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Human monocytes and macrophages express substance P and neurokinin-1 receptor
|The Journal of Immunology|1997|386
Depressive and Anxiety Disorders in Women With HIV Infection
|American Journal of Psychiatry|2002|377